Supplementary Data from Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy

• DOI: 10.1158/1078-0432.22472927.v1
• Publication Date: 2023-04-01T01:36:51Z
• Authors: Pierre Foidart; Cassandre Yip; Jean Radermacher; Silvia Blacher; Mehdi Lienard; Laetitia Montero-...; Erik Maquoi; Elodie Montaudon; Sophie Château-Jo...; Joëlle Collignon; Michel Coibion; Véronique Jossa; Elisabetta Marangoni; Agnès Noël; Nor Eddine Sounni; Guy Jerusalem

<p>Supplemental data include a Supplemental Table-1, Supplemental Figure 1, Supplemental Figure 2, Supplemental Figure 3, Supplemental Figure 4, Supplemental Figure 5 and Supplemental Figure 6. Supplemental Table-1 is related to Figure 1 Supplemental Figure 1 is related to Figure 2 Supplemental Figure 2 is related to Figure 5 Supplemental Figures 3-5 are related to Figure 6 Supplemental Figure 6 is related to Figure 1 and Figure 5</p>